Drug application
DARVON-N (PROPOXYPHENE NAPSYLATE)
Drugs@FDA NDA 016861 · AAIPHARMA LLC
Key facts
| Drug name | DARVON-N |
|---|---|
| Active ingredients | PROPOXYPHENE NAPSYLATE |
| Application type | NDA |
| Application number | 016861 |
| Company | AAIPHARMA LLC |
| Dosage forms | SUSPENSION, ORAL |
| Strength | 50MG/5ML |
| Marketing status | Discontinued |
| Reference listed drug | No |
| Latest submission class | Type 3 - New Dosage Form |
| Latest submission status date | Sep 9, 1971 |
At a glance
- 1–9 Submissions
- 10–99 Supplements
- None Label versions
- 1–9 Products
- None Therapeutic equivalents
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Drugs@FDA applications
Drugs@FDA covers FDA-approved brand-name and generic drugs and therapeutic biologics, with their applications (NDA, ANDA or BLA), products, submissions and labels.